Veru Advances Prostate Cancer Therapy VERU-111 to Phase 2 Portion of Trial
News
Veru said it initiated the Phase 2 portion of a clinical trial testing the safety and effectiveness of its investigational therapy, VERU-111, in men with metastatic castration-resistant prostate cancer (mCRPC) ... Read more